|
Portfolio All companies in the KD portfolio address an unmet medical need. A company is typically founded on an innovation with a strong IP position or skills that are difficult to replicate. Portfolio companies are primarily selected on the merit of their projects and the feasibility of concluding a development program through to a suitable proof of principle (POP). Pharmaceutical as well as medical technology applications are pursued irrespective of therapeutic use provided the innovation addresses a distinct medical need. Initially most of the companies have a cost effective virtual organization until POP. This is achieved by using experts from within the KD network who contribute to several companies on a part time basis as well as using CROs and CMOs. The operative support by KD starts immediately and recruitment of the management team is gradually intensified to meet a more complex environment as projects mature. For employment opportunities in the portfolio companies please contact the companies directly.
|